| (210) | Number of the EPO application | 17794488 |
| (220) | Filing date of the EPO application | 2017.10.18 |
| (80) | EPO patent specification publication (B) | EPB nr. 32/2023, 2023.08.09 |
| (110) | EPO patent number | 3529256 |
| (21) | Number of the application | e 2019 0949 |
| (71) | Name(s) of applicant(s), code of the country | SAGE THERAPEUTICS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | SALITURO Francesco G., US;
ROBICHAUD Albert J., US;
MARTINEZ BOTELLA Gabriel, US;
HARRISON Boyd L., US;
GRIFFIN Andrew, CA;
LA Daniel, US; |
| (73) | Name(s) of owner(s), code of the country | SAGE THERAPEUTICS, INC., US; |
| (54) | Title of the invention | OXYSTEROLS AND METHODS OF USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07J 9/00 (2006.01.01); A61K 31/575 (2006.01.01); A61P 25/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.09.30 |
| (30) | Priority | 201662409768 P, 2016.10.18, US; 201662409756 P, 2016.10.18, US |
| (86) | International application | PCT/US2017/057276, 2017.10.18 |
| (87) | International publication | WO 2018/075698, 2018.04.26 |